For specialists

Rationale for the use of ursodeoxycholic acid in the treatment of non-alcoholic steatohepatitis
Published in the journal «Bulletin of the club of pancreatologists» Vol 42 № 1’2019
Drug - induced liver injury: from pathogenesis to treatment
Published in the journal «Bulletin of the club of pancreatologists» Vol 46 № 1’2020
Biliary dyskinesias: traditional and modern views
Published in the journal «Bulletin of the club of pancreatologists» Vol 45 № 4’2019
Dynamics of lipid spectrum indices, endothelial function, and insulin resistance in patients with coronary heart disease in combination with non-alcoholic steatosis
Published in the journal «Zaporozhye Medical Journal» Vol 21 № 3 (114)’2019
Hepatological risk in the treatment of overweight and obesity: possible ways of prevention
Published in the journal «Health of Ukraine» № 4 (281)’2012
Some aspects of the use of fosfomycin in the treatment of postcoital cystitis in the practice of a dermatovenerologist
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 1 (76)’2020
The use of fosfomycin trometamol in modern clinical practice
Published in the journal «Ukrainian Journal of Perinatology and Pediatrics» № 1 (81)’2020
Experience of using the drug Fluzamed in chronic recurrent vulvovaginal candidiasis
Published in a journal «Women's Health» № 1 (67)’2012
Experience of using Fluzamed in the treatment of candidal balanitis and balanoposthitis
Published in a journal «Men's health» № 1’2012
Efficiency of using antifungal drugs in women with vaginal candidiasis on the background of papillomavirus infection
Published in the journal «Perinatology and pediatric. UKRAINE» № 2 (74)’2018

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design